Elecoglipron for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 4 registered trials.

Why this status

  1. 23 Jun 2026: Trial registered, NCT07662044
  2. 23 Jun 2026: Trial registered, NCT07662135
  3. 24 Jun 2026: Trial registered, NCT07664553
  4. 6 Jul 2026: Trial started, NCT07662044
  5. 6 Jul 2026: Trial started, NCT07662135
  6. 8 Jul 2026: Trial started, NCT07664553
  7. 20 Aug 2026: Trial registered, NCT07775404
  8. 21 Aug 2026: Trial started, NCT07775404

The trials

NCT07662044: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

State
Under way
Phase
Phase 3
People
800 planned
Started
6 Jul 2026
Primary completion
14 Jul 2028
Arms
Elecoglipron dose level 1 + dapagliflozin-matched placebo, Elecoglipron dose level 2 + dapagliflozin-matched placebo
Results
None posted
  1. 23 Jun 2026: Trial registered
  2. 6 Jul 2026: Trial started

NCT07662135: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

State
Under way
Phase
Phase 3
People
900 planned
Started
6 Jul 2026
Primary completion
13 Jul 2028
Arms
Elecoglipron dose level 1, Elecoglipron dose level 2
Results
None posted
  1. 23 Jun 2026: Trial registered
  2. 6 Jul 2026: Trial started

NCT07664553: A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

State
Under way
Phase
Phase 3
People
600 planned
Started
8 Jul 2026
Primary completion
23 May 2028
Arms
Elecoglipron dose level 1, Elecoglipron dose level 2
Results
None posted
  1. 24 Jun 2026: Trial registered
  2. 8 Jul 2026: Trial started

NCT07775404: A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

State
Under way
Phase
Phase 3
People
351 planned
Started
21 Aug 2026
Primary completion
6 Apr 2028
Arms
Arm 1 - Dose 1, Arm 2 - Dose 2
Results
None posted
  1. 20 Aug 2026: Trial registered
  2. 21 Aug 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.